The Therapeutic Radiographer/Radiation Therapist (RTT) is the professional with direct responsibility for treatment planning and treatment delivery in a safe environment as well as patient care, follow-up, and research.
In September, during prostate cancer awareness month, the Accuray Exchange is hosting a special webinar series to highlight the growing evidence and advances in prostate Stereotactic body radiotherapy (SBRT) and hypofractionated treatments using CyberKnife®️, TomoTherapy®️ and Radixact®️ Systems. In this series you will hear from leading experts from the field of prostate radiation oncology, sharing their […]
Join Medical Physicist Jun Yang, Ph.D., DABR from Radiation Physics Solutions, United States and JunXin Oncology Group, China as he shares his experience in the commissioning of the CyberKnife® Treatment Delivery System.
Stereotactic radiotherapy for lung cancer has seen an increase in the number of cases treated, especially in elderly patients. In addition, the indication for stereotactic body radiotherapy(SBRT) for oligometastatic cases is rapidly expanding, as well as an increasing number of SBRT treatments in the abdominal region. For SBRT in the abdominal region and lower lung field, measures against the respiratory motion are important. Synchrony® is a technology that enables tracking and irradiation of moving targets. It is expected to guarantee the dose to the moving tumor and reduce the irradiation volume of normal tissues. However, to provide safe and reliable treatment, it is necessary to understand the Synchrony mechanism and its characteristics.
Powerful synergies lead to meaningful innovations. As we work to improve patient outcomes, Accuray and Brainlab partner to enable the stereotactic radiosurgery community to leverage the precision of Accuray CyberKnife® treatment delivery system in combination with Brainlab Elements planning software.
The webinar will focus on the dose and fractionation of spine SBRT referring to the latest published studies. Primary SBRT and reirradiation will be addressed, as well as recent data on doses/fractionation. Case reports will be shared demonstrating clinical and technical aspects of spinal SBRT delivery.
Since the publication of Task Group 148 in 2010, the TomoTherapy platform has undergone substantial development involving treatment delivery, image guidance, motion management, and treatment planning systems (TPS). New hardware and software capabilities have dramatically changed its delivery and planning characteristics. Task Group 306 was formed to provide guidance on the implementation, management, and quality assurance for these technological advances. In this session, the work of Task Group 306 will be presented. Changes to the TomoTherapy platform since 2010 and the impact on clinical delivery and QA practices, including QA tests and tolerance limits will be presented.
TomoTherapy® based dose-escalated radiation therapy for painful bone metastases using the Scan-Plan-QA-Treat workflow
In this webinar, Drs. Muller and Wijesooriya will discuss their experience with same day simulation, planning, and treatment of painful osseous metastases with dose escalated radiation therapy using the TomoTherapy platform. They will also discuss the prospective trials, and the workflow performed at the University of Virginia. The session will be moderated by Dr. Paul Read.
In this webinar the presenters will share their approach to planning brain metastases, lung tumors, and prostate tumors using the VOLO optimizer. This will be followed by a moderated Q&A session.
Dr. Paolo Francescon, Vicenza, Italy